These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28029750)

  • 1. "Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements.
    Palmowski Y; Buttgereit T; Dejaco C; Bijlsma JW; Matteson EL; Voshaar M; Boers M; Buttgereit F
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1134-1141. PubMed ID: 28029750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.
    Gaujoux-Viala C; Gossec L
    Ann N Y Acad Sci; 2014 May; 1318():32-40. PubMed ID: 24827544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
    Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
    Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis.
    Luís M; Freitas J; Costa F; Buttgereit F; Boers M; Jap DS; Santiago T
    Expert Opin Drug Saf; 2019 Jul; 18(7):581-590. PubMed ID: 31056959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids in rheumatoid arthritis: current status and future studies.
    Hua C; Buttgereit F; Combe B
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1111-1124. PubMed ID: 28620917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucocorticoid therapy in rheumatoid arthritis - pro].
    Pongratz G
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review.
    Lopez-Olivo MA; Kallen MA; Ortiz Z; Skidmore B; Suarez-Almazor ME
    Arthritis Rheum; 2008 Nov; 59(11):1625-38. PubMed ID: 18975351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion.
    Mouterde G; Dernis E; Ruyssen-Witrand A; Claudepierre P; Schaeverbeke T; Cantagrel A; Gaudin P; Maillefert JF; Pham T; Saraux A; Tebib J; Wendling D; Fautrel B; Le Loët X
    Joint Bone Spine; 2010 Dec; 77(6):597-603. PubMed ID: 20594896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.
    Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V;
    J Rheumatol; 2012 Aug; 39(8):1583-602. PubMed ID: 22707613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II.
    Hazlewood GS; Akhavan P; Schieir O; Marshall D; Tomlinson G; Bykerk V; Bombardier C
    J Clin Epidemiol; 2014 Nov; 67(11):1274-85. PubMed ID: 25240769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks.
    Townsend HB; Saag KG
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S77-82. PubMed ID: 15552519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis and glucocorticoids; the contribution of a literature search to the development of a EULAR recommendation on treatment with glucocorticoids in RA.
    Gorter SL
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S77-80. PubMed ID: 22018189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid use in rheumatoid arthritis patients and the onset of pneumonia: a systematic review and meta-analysis.
    Elsouri KN; Arboleda V; Basbous L; Heiser S; Collins DP; Ragusa P; Baxter C; Cabrera D; Akhand T; Stermer E; Sharma K; Seguro C; Hardigan P; Kesselman M; Beckler MD
    J Osteopath Med; 2023 Apr; 123(4):179-186. PubMed ID: 36691851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Albrecht K; Krüger K; Wollenhaupt J; Alten R; Backhaus M; Baerwald C; Bolten W; Braun J; Burkhardt H; Burmester GR; Gaubitz M; Gause A; Gromnica-Ihle E; Kellner H; Kuipers J; Krause A; Lorenz HM; Manger B; Nüßlein H; Pott HG; Rubbert-Roth A; Schneider M; Specker C; Schulze-Koops H; Tony HP; Wassenberg S; Müller-Ladner U;
    Rheumatol Int; 2014 Jan; 34(1):1-9. PubMed ID: 23942828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Bykerk VP; Akhavan P; Hazlewood GS; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Bombardier C;
    J Rheumatol; 2012 Aug; 39(8):1559-82. PubMed ID: 21921096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
    Da Silva JA; Jacobs JW; Kirwan JR; Boers M; Saag KG; Inês LB; de Koning EJ; Buttgereit F; Cutolo M; Capell H; Rau R; Bijlsma JW
    Ann Rheum Dis; 2006 Mar; 65(3):285-93. PubMed ID: 16107513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.